BetRivers vs a2z Radiology AI

Side-by-side comparison of AI visibility scores, market position, and capabilities

BetRivers

EstablishedEntertainment & Gaming

Sports Betting & iGaming

U.S. regional online sportsbook and iGaming brand operated by Rush Street Interactive; powered by RSI's proprietary technology platform, active in 15+ states.

About

BetRivers is a U.S. online sportsbook and iGaming brand operated by Rush Street Interactive (RSI), a Chicago-based gaming company founded in 2012 by Neil Bluhm and Greg Carlin. RSI operates BetRivers in 15+ states and internationally under the PlaySugarHouse brand (Pennsylvania, New Jersey) and SugarHouse Online Casino. Unlike major competitors, RSI built its entire technology stack in-house, allowing faster product iteration and avoiding third-party platform fees. RSI went public via SPAC in 2020 (NYSE: RSI).\n\nBetRivers differentiates through a customer service-first strategy and a loyalty program, iRush Rewards, which offers more transparent and valuable rewards than competitors. The brand is particularly strong in Pennsylvania and Illinois—markets where it holds meaningful share—and in Ontario, Canada's regulated online gaming market, where it competes aggressively against international operators. BetRivers' focus on the Midwest and Great Lakes region reflects RSI's physical casino roots.\n\nRush Street Interactive's proprietary technology powers both BetRivers in North America and multiple international clients under a B2B licensing model. RSI reported healthy financials in 2025 with positive Adjusted EBITDA, driven by iGaming growth in Pennsylvania and Michigan. While BetRivers holds a smaller national market share than FanDuel, DraftKings, or BetMGM, it maintains strong brand loyalty in its core markets and a differentiated value proposition on customer service and rewards.

Full profile

a2z Radiology AI

EmergingEnterprise AI

Medical Imaging AI

a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.

About

a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.

Full profile

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.